Cargando…

Identifying amyloid-related diseases by mapping mutations in low-complexity protein domains to pathologies

Proteins including FUS, hnRNPA2, and TDP-43 reversibly aggregate into amyloid-like fibrils through interactions of their low-complexity domains (LCDs). Mutations in LCDs can promote irreversible amyloid aggregation and disease. We introduce a computational approach to identify mutations in LCDs of d...

Descripción completa

Detalles Bibliográficos
Autores principales: Murray, Kevin A., Hughes, Michael P., Hu, Carolyn J., Sawaya, Michael R., Salwinski, Lukasz, Pan, Hope, French, Samuel W., Seidler, Paul M., Eisenberg, David S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205782/
https://www.ncbi.nlm.nih.gov/pubmed/35637421
http://dx.doi.org/10.1038/s41594-022-00774-y
_version_ 1784729201138466816
author Murray, Kevin A.
Hughes, Michael P.
Hu, Carolyn J.
Sawaya, Michael R.
Salwinski, Lukasz
Pan, Hope
French, Samuel W.
Seidler, Paul M.
Eisenberg, David S.
author_facet Murray, Kevin A.
Hughes, Michael P.
Hu, Carolyn J.
Sawaya, Michael R.
Salwinski, Lukasz
Pan, Hope
French, Samuel W.
Seidler, Paul M.
Eisenberg, David S.
author_sort Murray, Kevin A.
collection PubMed
description Proteins including FUS, hnRNPA2, and TDP-43 reversibly aggregate into amyloid-like fibrils through interactions of their low-complexity domains (LCDs). Mutations in LCDs can promote irreversible amyloid aggregation and disease. We introduce a computational approach to identify mutations in LCDs of disease-associated proteins predicted to increase propensity for amyloid aggregation. We identify several disease-related mutations in the intermediate filament protein keratin-8 (KRT8). Atomic structures of wild-type and mutant KRT8 segments confirm the transition to a pleated strand capable of amyloid formation. Biochemical analysis reveals KRT8 forms amyloid aggregates, and the identified mutations promote aggregation. Aggregated KRT8 is found in Mallory–Denk bodies, observed in hepatocytes of livers with alcoholic steatohepatitis (ASH). We demonstrate that ethanol promotes KRT8 aggregation, and KRT8 amyloids co-crystallize with alcohol. Lastly, KRT8 aggregation can be seeded by liver extract from people with ASH, consistent with the amyloid nature of KRT8 aggregates and the classification of ASH as an amyloid-related condition.
format Online
Article
Text
id pubmed-9205782
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group US
record_format MEDLINE/PubMed
spelling pubmed-92057822022-06-19 Identifying amyloid-related diseases by mapping mutations in low-complexity protein domains to pathologies Murray, Kevin A. Hughes, Michael P. Hu, Carolyn J. Sawaya, Michael R. Salwinski, Lukasz Pan, Hope French, Samuel W. Seidler, Paul M. Eisenberg, David S. Nat Struct Mol Biol Article Proteins including FUS, hnRNPA2, and TDP-43 reversibly aggregate into amyloid-like fibrils through interactions of their low-complexity domains (LCDs). Mutations in LCDs can promote irreversible amyloid aggregation and disease. We introduce a computational approach to identify mutations in LCDs of disease-associated proteins predicted to increase propensity for amyloid aggregation. We identify several disease-related mutations in the intermediate filament protein keratin-8 (KRT8). Atomic structures of wild-type and mutant KRT8 segments confirm the transition to a pleated strand capable of amyloid formation. Biochemical analysis reveals KRT8 forms amyloid aggregates, and the identified mutations promote aggregation. Aggregated KRT8 is found in Mallory–Denk bodies, observed in hepatocytes of livers with alcoholic steatohepatitis (ASH). We demonstrate that ethanol promotes KRT8 aggregation, and KRT8 amyloids co-crystallize with alcohol. Lastly, KRT8 aggregation can be seeded by liver extract from people with ASH, consistent with the amyloid nature of KRT8 aggregates and the classification of ASH as an amyloid-related condition. Nature Publishing Group US 2022-05-30 2022 /pmc/articles/PMC9205782/ /pubmed/35637421 http://dx.doi.org/10.1038/s41594-022-00774-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Murray, Kevin A.
Hughes, Michael P.
Hu, Carolyn J.
Sawaya, Michael R.
Salwinski, Lukasz
Pan, Hope
French, Samuel W.
Seidler, Paul M.
Eisenberg, David S.
Identifying amyloid-related diseases by mapping mutations in low-complexity protein domains to pathologies
title Identifying amyloid-related diseases by mapping mutations in low-complexity protein domains to pathologies
title_full Identifying amyloid-related diseases by mapping mutations in low-complexity protein domains to pathologies
title_fullStr Identifying amyloid-related diseases by mapping mutations in low-complexity protein domains to pathologies
title_full_unstemmed Identifying amyloid-related diseases by mapping mutations in low-complexity protein domains to pathologies
title_short Identifying amyloid-related diseases by mapping mutations in low-complexity protein domains to pathologies
title_sort identifying amyloid-related diseases by mapping mutations in low-complexity protein domains to pathologies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205782/
https://www.ncbi.nlm.nih.gov/pubmed/35637421
http://dx.doi.org/10.1038/s41594-022-00774-y
work_keys_str_mv AT murraykevina identifyingamyloidrelateddiseasesbymappingmutationsinlowcomplexityproteindomainstopathologies
AT hughesmichaelp identifyingamyloidrelateddiseasesbymappingmutationsinlowcomplexityproteindomainstopathologies
AT hucarolynj identifyingamyloidrelateddiseasesbymappingmutationsinlowcomplexityproteindomainstopathologies
AT sawayamichaelr identifyingamyloidrelateddiseasesbymappingmutationsinlowcomplexityproteindomainstopathologies
AT salwinskilukasz identifyingamyloidrelateddiseasesbymappingmutationsinlowcomplexityproteindomainstopathologies
AT panhope identifyingamyloidrelateddiseasesbymappingmutationsinlowcomplexityproteindomainstopathologies
AT frenchsamuelw identifyingamyloidrelateddiseasesbymappingmutationsinlowcomplexityproteindomainstopathologies
AT seidlerpaulm identifyingamyloidrelateddiseasesbymappingmutationsinlowcomplexityproteindomainstopathologies
AT eisenbergdavids identifyingamyloidrelateddiseasesbymappingmutationsinlowcomplexityproteindomainstopathologies